EFFECT OF ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR RECEPTORS ON MEMORY OF INHIBITORY AVOIDANCE IN RATS

被引:26
|
作者
JERUSALINSKY, D [1 ]
FIN, C [1 ]
QUILLFELDT, JA [1 ]
FERREIRA, MBC [1 ]
SCHMITZ, PK [1 ]
DASILVA, RC [1 ]
WALZ, R [1 ]
BAZAN, NG [1 ]
MEDINA, JH [1 ]
IZQUIERDO, I [1 ]
机构
[1] UFRGS CTR,INST BIOCIENCIAS,DEPT BIOQUIM,CTR MEMORIA,BR-90046900 PORTO ALEGRE,RS,BRAZIL
来源
BEHAVIORAL AND NEURAL BIOLOGY | 1994年 / 62卷 / 01期
关键词
D O I
10.1016/S0163-1047(05)80052-4
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Platelet-activating factor (PAF) is present in the brain. It enhances glutamate release and long-term potentiation (LTP) through an action on synaptic membrane receptors sensitive to the antagonist, BN 52021, and has been proposed as a retrograde messenger in the genesis of LTP. In addition, PAF has other, metabolic actions mediated by microsomal receptors sensitive to the antagonist, BN 50730. We investigated the effect on memory of the pre- or post-training infusion of BN 52021 or BN 50730 into the hippocampus and that of BN 52021 in the amygdala and the entorhinal cortex. Male Wistar rats were implanted bilaterally with cannulae aimed at these brain regions. After recovery from surgery, the animals were trained in step-down inhibitory avoidance using a 0.5-mA foot shock and tested for retention 24 h later. BN 52021 (0.5 mu g/side) was amnestic when given into the hippocampus or the amygdala either before or immediately after training but not 30 or 100 min later. BN 52021 was also amnestic when given into the entorhinal cortex 100 but not 0 or 300 min after training. Intrahippocampally administered BN 50730 had no effect on memory. The findings are compatible with the suggestion from previous findings that memory of this task depends on the generation of LTP at the time of training in hippocampus and amygdala and, 90-180 min later, in the entorhinal cortex. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [1] PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    KOLTAI, M
    BRAQUET, PG
    CLINICAL REVIEWS IN ALLERGY, 1994, 12 (04): : 361 - 380
  • [2] ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR
    TOKUMURA, A
    TSUKATANI, H
    SEIKAGAKU, 1985, 57 (12): : 1618 - 1623
  • [3] PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    SAUNDERS, RN
    HANDLEY, DA
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1987, 27 : 237 - 255
  • [4] PLATELET-ACTIVATING-FACTOR ANTAGONISTS INTERACT WITH GABA-A RECEPTORS
    MILLER, LG
    BAZAN, NG
    ROY, RB
    CLOSTRE, F
    GAVER, A
    BRAQUET, P
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1991, 74 (02): : 253 - 256
  • [5] MEMORY ENHANCEMENT BY INTRAHIPPOCAMPAL, INTRAAMYGDALA, OR INTRAENTORHINAL INFUSION OF PLATELET-ACTIVATING-FACTOR MEASURED IN AN INHIBITORY AVOIDANCE TASK
    IZQUIERDO, I
    FIN, C
    SCHMITZ, PK
    DASILVA, RC
    JERUSALINSKY, D
    QUILLFELDT, JA
    FERREIRA, MBG
    MEDINA, JH
    BAZAN, NG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) : 5047 - 5051
  • [6] EFFECTS OF PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTS ON INTRACELLULAR PLATELET-ACTIVATING-FACTOR FUNCTION IN NEUTROPHILS
    KOIKE, H
    IMANISHI, N
    NATSUME, Y
    MOROOKA, S
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (03): : 299 - 309
  • [7] EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONISTS IN DIFFERENT MODELS OF THROMBOSIS
    SETH, P
    KUMARI, R
    DIKSHIT, M
    SRIMAL, RC
    THROMBOSIS RESEARCH, 1994, 76 (06) : 503 - 512
  • [8] PLATELET-ACTIVATING-FACTOR ANTAGONISTS AND INFECTED CIRRHOSIS
    DENIZOT, Y
    NATHAN, N
    GASTROENTEROLOGY, 1993, 105 (04) : 1267 - 1267
  • [9] PLATELET-ACTIVATING-FACTOR ANTAGONISTS IN EXPERIMENTAL SHOCK
    MUACEVIC, G
    HEUER, HO
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (08): : 1001 - 1004
  • [10] PLATELET-ACTIVATING-FACTOR ANTAGONISTS AND OCULAR INFLAMMATION
    BAZAN, HEP
    TAO, Y
    HURST, JS
    JOURNAL OF OCULAR PHARMACOLOGY, 1994, 10 (01): : 319 - 327